ABUS Arbutus initiates international patent infringement enforcement actions against Pfizer and Biontech, receives first payment from Modern

ABUS Arbutus initiates international patent infringement enforcement actions against Pfizer and Biontech, receives first payment from Moderna settlement agreement and announces intent to return capital to shareholders Arbutus Biopharma Corp - receives about $178M from Moderna under March 2026 settlement agreement - Expects to return up to $230M in capital to shareholders